Tezampanel

CAS No. 150131-78-5

Tezampanel( LY 293558 | NGX 424 )

Catalog No. M12089 CAS No. 150131-78-5

Tezampanel (LY 293558, NGX 424) is a competitive antagonist of the AMPA and kainate receptors with selectivity for the GluR5 subtype of the kainate receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tezampanel
  • Note
    Research use only, not for human use.
  • Brief Description
    Tezampanel (LY 293558, NGX 424) is a competitive antagonist of the AMPA and kainate receptors with selectivity for the GluR5 subtype of the kainate receptor.
  • Description
    Tezampanel (LY 293558, NGX 424) is a competitive antagonist of the AMPA and kainate receptors with selectivity for the GluR5 subtype of the kainate receptor; has neuroprotective and anticonvulsant properties, also has anxiolytic effects in animal studies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LY 293558 | NGX 424
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR
  • Research Area
    Neurological Disease
  • Indication
    Migraine

Chemical Information

  • CAS Number
    150131-78-5
  • Formula Weight
    279.344
  • Molecular Formula
    C13H21N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1CC2CNC(CC2CC1CCC3=NNN=N3)C(=O)O
  • Chemical Name
    (3S,4aR,6R,8aR)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ornstein PL, et al. J Med Chem. 1993 Jul 9;36(14):2046-8. 2. LeBlanc MH, et al. Stroke. 1995 Oct;26(10):1908-14; discussion 1914-5. 3. Benvenga MJ, et al. J Pharmacol Exp Ther. 1995 Oct;275(1):164-70.
molnova catalog
related products
  • TAK-653

    TAK-653, a selective positive allosteric modulator (PAM) of AMPA receptors exhibiting minimal agonistic activity, elicits an antidepressant-like response while maintaining a favorable safety profile in rat models.

  • Conantokin G

    GluN2B (formally NR2B) selective, competitive antagonist of the NMDA receptor. Blocks NMDA-evoked current in mouse cortical neurons (IC50 = 480 nM); also inhibits NMDA-evoked responses in oocytes expressing GluN2B (formally NR2B), but not GluN2A (formally NR2A), subunits (IC50 ~300 nM). Exhibits neuroprotective properties in vivo and in vitro.

  • VPC13566

    (S)-(-)-5-Fluorowillardiine is an AMPA receptor-specific agonist.